Bruno Van Vlem

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 589 citations · Full text

Urology, Renal Disease, Renal Events +7

Multicenter Randomized Controlled Trial of Vitamin K Antagonist Replacement by Rivaroxaban with or without Vitamin K2 in Hemodialysis Patients with Atrial Fibrillation: the Valkyrie Study

An S. De Vriese, Rogier Caluwé, Lotte Pyfferoen et al. · Journal of the American Society of Nephrology · 2019 · 168 citations · Full text

Hypertension, Heart Failure, Vitamin K Status +22

The Marmara earthquake: Epidemiological analysis of the victims with nephrological problems

Mehmet Şükrü Sever, Ekrem Erek, Raymond Vanholder et al. · Kidney International · 2001 · 163 citations · Full text

Dose-Finding Study of Rivaroxaban in Hemodialysis Patients

An S. De Vriese, Rogier Caluwé, Els Bailleul et al. · American Journal of Kidney Diseases · 2015 · 142 citations

Therapeutic Drug Monitoring, Hemodialysis, Hemodialysis Patients +7

Blue Native Polyacrylamide Gel Electrophoresis: A Powerful Tool in Diagnosis of Oxidative Phosphorylation Defects

Rudy Van Coster, Joél Smet, Edith George et al. · Pediatric Research · 2001 · 136 citations · Full text

Biochemistry, Bioanalysis, Oxidative Phosphorylation Defects +8